> top > docs > PMC:3342329 > spans > 4459-6031 > annotations

PMC:3342329 / 4459-6031 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T1366 1540-1544 Protein denotes CCR5
T1365 1408-1412 Protein denotes CCL5
T1364 1351-1355 Protein denotes CCR5
T1363 670-679 Negative_regulation denotes deficient
T1362 630-640 Gene_expression denotes expression
T1361 613-619 Protein denotes GM-CSF
T1360 607-611 Protein denotes IL-3
T1359 601-605 Protein denotes IL-2
T1358 587-596 Positive_regulation denotes essential
T1357 578-583 Protein denotes c-Rel
T1356 545-554 Negative_regulation denotes deficient
T1355 539-544 Protein denotes c-Rel
T1309 1540-1544 Protein denotes CCR5
T1308 1408-1412 Protein denotes CCL5
T1307 1351-1355 Protein denotes CCR5
T1306 613-619 Protein denotes GM-CSF
T1305 607-611 Protein denotes IL-3
T1304 601-605 Protein denotes IL-2
T1303 578-583 Protein denotes c-Rel
T1302 539-544 Protein denotes c-Rel
R779 T1355 T1356 themeOf c-Rel,deficient
R780 T1356 T1358 causeOf deficient,essential
R781 T1357 T1358 causeOf c-Rel,essential
R782 T1359 T1362 themeOf IL-2,expression
R783 T1360 T1362 themeOf IL-3,expression
R784 T1361 T1362 themeOf GM-CSF,expression
R785 T1362 T1358 themeOf expression,essential

testone

Id Subject Object Predicate Lexical cue
T1267 1356-1366 Gene_expression denotes expression
T1266 1337-1347 Negative_regulation denotes inhibition
T1265 670-679 Negative_regulation denotes deficient
T1264 630-640 Gene_expression denotes expression
T1263 587-596 Positive_regulation denotes essential
T1262 545-554 Negative_regulation denotes deficient
T1235 1540-1544 Protein denotes CCR5
T1234 1408-1412 Protein denotes CCL5
T1233 1351-1355 Protein denotes CCR5
T1232 613-619 Protein denotes GM-CSF
T1231 607-611 Protein denotes IL-3
T1230 601-605 Protein denotes IL-2
T1229 578-583 Protein denotes c-Rel
T1228 539-544 Protein denotes c-Rel
R752 T1228 T1262 themeOf c-Rel,deficient
R753 T1229 T1263 causeOf c-Rel,essential
R754 T1230 T1264 themeOf IL-2,expression
R755 T1231 T1264 themeOf IL-3,expression
R756 T1232 T1264 themeOf GM-CSF,expression
R757 T1233 T1267 themeOf CCR5,expression
R764 T1262 T1263 causeOf deficient,essential
R765 T1264 T1263 themeOf expression,essential
R766 T1267 T1266 themeOf expression,inhibition

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T2928 1540-1544 Protein denotes CCR5
T2927 1408-1412 Protein denotes CCL5
T2926 1351-1355 Protein denotes CCR5
T2925 613-619 Protein denotes GM-CSF
T2924 607-611 Protein denotes IL-3
T2923 601-605 Protein denotes IL-2
T2922 578-583 Protein denotes c-Rel
T2921 539-544 Protein denotes c-Rel
T2959 1337-1347 Negative_regulation denotes inhibition
T2958 1356-1366 Gene_expression denotes expression
T2957 545-554 Negative_regulation denotes deficient
T2956 587-596 Positive_regulation denotes essential
T2955 630-640 Gene_expression denotes expression
R1896 T2921 T2957 themeOf c-Rel,deficient
R1899 T2922 T2956 causeOf c-Rel,essential
R1901 T2922 T2956 causeOf c-Rel,essential
R1902 T2922 T2956 causeOf c-Rel,essential
R1904 T2923 T2956 themeOf IL-2,essential
R1907 T2923 T2955 themeOf IL-2,expression
R1908 T2924 T2956 themeOf IL-3,essential
R1913 T2924 T2955 themeOf IL-3,expression
R1914 T2925 T2956 themeOf GM-CSF,essential
R1915 T2925 T2955 themeOf GM-CSF,expression
R1917 T2926 T2958 themeOf CCR5,expression
R1939 T2958 T2959 themeOf expression,inhibition

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T4221 1356-1366 Gene_expression denotes expression
T4220 1337-1347 Negative_regulation denotes inhibition
T4219 545-554 Negative_regulation denotes deficient
T4218 587-596 Positive_regulation denotes essential
T4217 630-640 Gene_expression denotes expression
T4189 1408-1412 Protein denotes CCL5
T4188 1351-1355 Protein denotes CCR5
T4187 613-619 Protein denotes GM-CSF
T4186 607-611 Protein denotes IL-3
T4185 601-605 Protein denotes IL-2
T4184 578-583 Protein denotes c-Rel
T4183 539-544 Protein denotes c-Rel
T4190 1540-1544 Protein denotes CCR5
R3018 T4217 T4218 themeOf expression,essential
R3019 T4217 T4218 themeOf expression,essential
R3020 T4217 T4218 themeOf expression,essential
R3022 T4221 T4220 themeOf expression,inhibition
R2986 T4183 T4219 themeOf c-Rel,deficient
R2987 T4184 T4218 causeOf c-Rel,essential
R2988 T4184 T4218 causeOf c-Rel,essential
R2989 T4184 T4218 causeOf c-Rel,essential
R2990 T4184 T4218 causeOf c-Rel,essential
R2991 T4184 T4218 causeOf c-Rel,essential
R2992 T4184 T4218 causeOf c-Rel,essential
R2993 T4185 T4218 themeOf IL-2,essential
R2994 T4185 T4217 themeOf IL-2,expression
R2995 T4186 T4218 themeOf IL-3,essential
R2996 T4186 T4217 themeOf IL-3,expression
R2998 T4187 T4218 themeOf GM-CSF,essential
R2999 T4187 T4217 themeOf GM-CSF,expression
R3000 T4188 T4221 themeOf CCR5,expression

2_test

Id Subject Object Predicate Lexical cue
22567084-12001991-91707024 176-178 12001991 denotes 26
22567084-15256061-91707025 318-320 15256061 denotes 27
22567084-9990849-91707026 421-423 9990849 denotes 28
22567084-15313403-91707027 523-525 15313403 denotes 29
22567084-8622948-91707028 659-661 8622948 denotes 30
22567084-11704834-91707029 855-857 11704834 denotes 31
22567084-19469019-91707030 1368-1370 19469019 denotes 32
22567084-19073147-91707031 1468-1470 19073147 denotes 33

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T2519 1560-1571 NN denotes development
T2518 1554-1559 NN denotes tumor
T2517 1545-1553 VB denotes mediated
T2516 1540-1544 NN denotes CCR5
T2515 1537-1539 IN denotes in
T2514 1528-1536 VB denotes involved
T2513 1525-1527 VB denotes be
T2512 1519-1524 MD denotes could
T2511 1513-1518 NN denotes NF-κB
T2510 1510-1512 IN denotes of
T2509 1499-1509 NN denotes inhibition
T2508 1494-1498 IN denotes that
T2507 1485-1493 JJ denotes possible
T2506 1482-1484 VB denotes is
T2505 1479-1481 PRP denotes it
T2504 1477-1478 -COMMA- denotes ,
T2503 1473-1477 RB denotes Thus
T2502 1470-1471 -RRB- denotes ]
T2501 1468-1470 CD denotes 33
T2500 1467-1468 -LRB- denotes [
T2499 1456-1466 NN denotes metastasis
T2498 1451-1455 NN denotes lung
T2497 1447-1450 CC denotes and
T2496 1445-1446 -RRB- denotes )
T2495 1444-1445 CD denotes 5
T2494 1443-1444 -LRB- denotes (
T2493 1434-1442 NN denotes motility
T2492 1427-1433 NN denotes cancer
T2491 1422-1426 JJ denotes oral
T2490 1408-1421 JJ denotes CCL5-mediated
T2489 1398-1407 VB denotes increases
T2488 1393-1397 RB denotes also
T2487 1387-1392 NN denotes NF-κB
T2486 1384-1386 IN denotes of
T2485 1373-1383 NN denotes Activation
T2484 1370-1371 -RRB- denotes ]
T2483 1368-1370 CD denotes 32
T2482 1367-1368 -LRB- denotes [
T2481 1356-1366 NN denotes expression
T2480 1351-1355 NN denotes CCR5
T2479 1348-1350 IN denotes of
T2478 1337-1347 NN denotes inhibition
T2477 1334-1336 IN denotes by
T2476 1325-1333 NN denotes lymphoma
T2475 1316-1324 NN denotes effusion
T2474 1308-1315 JJ denotes primary
T2473 1305-1307 IN denotes of
T2472 1299-1304 NN denotes death
T2471 1294-1298 NN denotes cell
T2470 1286-1293 VB denotes induces
T2469 1284-1285 -RRB- denotes )
T2468 1279-1284 NN denotes DHMEQ
T2467 1278-1279 -LRB- denotes (
T2466 1246-1277 NN denotes dehydroxymethyl-epoxyquinomicin
T2465 1243-1245 IN denotes by
T2464 1237-1242 NN denotes NF-κB
T2463 1234-1236 IN denotes of
T2462 1223-1233 NN denotes inhibition
T2461 1218-1222 IN denotes that
T2460 1209-1217 VB denotes reported
T2459 1205-1208 VB denotes was
T2458 1202-1204 PRP denotes It
T2457 1190-1200 NN denotes metastasis
T2456 1186-1189 CC denotes and
T2455 1179-1185 NN denotes growth
T2454 1173-1178 NN denotes tumor
T2453 1160-1172 JJ denotes CCR-mediated
T2452 1157-1159 IN denotes of
T2451 1146-1156 NN denotes regulation
T2450 1142-1145 DT denotes the
T2449 1139-1141 IN denotes in
T2448 1129-1138 JJ denotes important
T2447 1126-1128 VB denotes is
T2446 1120-1125 NN denotes NF-κB
T2445 1117-1119 IN denotes of
T2444 1106-1116 NN denotes Activation
T2443 1093-1104 NN denotes lymphokines
T2442 1085-1092 NN denotes killing
T2441 1079-1084 NN denotes tumor
T2440 1076-1078 IN denotes of
T2439 1065-1075 NN denotes production
T2438 1061-1064 DT denotes the
T2437 1050-1060 VB denotes increasing
T2436 1048-1049 -RRB- denotes )
T2435 1047-1048 CD denotes 3
T2434 1046-1047 -LRB- denotes (
T2433 1043-1045 CC denotes or
T2432 1030-1042 NN denotes infiltration
T2431 1018-1029 NN denotes lymphocytes
T2430 1010-1017 NN denotes killing
T2429 1004-1009 NN denotes tumor
T2428 992-1003 VB denotes stimulating
T2427 990-991 -RRB- denotes )
T2426 989-990 CD denotes 2
T2425 988-989 -LRB- denotes (
T2424 986-987 -COMMA- denotes ,
T2423 981-986 NN denotes death
T2422 976-980 NN denotes cell
T2421 969-975 NN denotes cancer
T2420 959-968 JJ denotes apoptotic
T2419 949-958 VB denotes affecting
T2418 940-948 RB denotes directly
T2417 938-939 -RRB- denotes )
T2416 937-938 LS denotes 1
T2415 936-937 -LRB- denotes (
T2414 933-935 IN denotes by
T2413 926-932 NN denotes growth
T2412 921-925 NN denotes cell
T2411 914-920 NN denotes cancer
T2410 906-913 VB denotes prevent
T2409 903-905 TO denotes to
T2408 894-902 VB denotes targeted
T2407 884-893 RB denotes specially
T2406 881-883 VB denotes be
T2405 877-880 MD denotes can
T2404 871-876 NN denotes NF-κB
T2403 869-870 -COMMA- denotes ,
T2402 860-869 RB denotes Therefore
T2401 857-858 -RRB- denotes ]
T2400 855-857 CD denotes 31
T2399 854-855 -LRB- denotes [
T2398 849-853 NN denotes host
T2397 845-848 DT denotes the
T2396 842-844 IN denotes in
T2395 832-841 NN denotes responses
T2394 825-831 JJ denotes immune
T2393 817-824 JJ denotes humoral
T2392 813-816 CC denotes and
T2391 806-812 JJ denotes innate
T2390 801-805 CC denotes both
T2389 791-800 VB denotes affecting
T2388 779-790 NN denotes macrophages
T2387 775-778 CC denotes and
T2386 769-774 NN denotes cells
T2385 767-768 NN denotes T
T2384 764-766 IN denotes in
T2383 756-763 NN denotes factors
T2382 749-755 NN denotes growth
T2381 745-748 CC denotes and
T2380 735-744 NN denotes cytokines
T2379 727-734 JJ denotes various
T2378 724-726 IN denotes of
T2377 713-723 NN denotes deficiency
T2376 697-712 JJ denotes tissue-specific
T2375 695-696 DT denotes a
T2374 690-694 VB denotes have
T2373 685-689 RB denotes also
T2372 680-684 NN denotes mice
T2371 664-679 JJ denotes C-Rel-deficient
T2370 661-662 -RRB- denotes ]
T2369 659-661 CD denotes 30
T2368 658-659 -LRB- denotes [
T2367 646-657 NN denotes lymphocytes
T2366 644-645 NN denotes T
T2365 641-643 IN denotes in
T2364 630-640 NN denotes expression
T2363 625-629 NN denotes IFNγ
T2362 621-624 CC denotes and
T2361 619-620 -COMMA- denotes ,
T2360 613-619 NN denotes GM-CSF
T2359 611-612 -COMMA- denotes ,
T2358 607-611 NN denotes IL-3
T2357 605-606 -COMMA- denotes ,
T2356 601-605 NN denotes IL-2
T2355 597-600 IN denotes for
T2354 587-596 JJ denotes essential
T2353 584-586 VB denotes is
T2352 578-583 NN denotes c-Rel
T2351 573-577 IN denotes that
T2350 560-572 VB denotes demonstrated
T2349 555-559 NN denotes mice
T2348 539-554 JJ denotes c-Rel-deficient
T2347 536-538 IN denotes on
T2346 528-535 NN denotes Studies
T2345 525-526 -RRB- denotes ]
T2344 523-525 CD denotes 29
T2343 522-523 -LRB- denotes [
T2342 513-521 RB denotes normally
T2341 504-512 VB denotes function
T2340 501-503 TO denotes to
T2339 494-500 NN denotes system
T2338 487-493 JJ denotes immune
T2337 483-486 DT denotes the
T2336 479-482 IN denotes for
T2335 470-478 VB denotes required
T2334 467-469 VB denotes is
T2333 464-466 PRP denotes it
T2332 462-463 -COMMA- denotes ,
T2331 456-462 NN denotes growth
T2330 450-455 NN denotes tumor
T2329 441-449 VB denotes promotes
T2328 435-440 NN denotes NF-κB
T2327 426-434 IN denotes Although
T2326 423-424 -RRB- denotes ]
T2325 421-423 CD denotes 28
T2324 420-421 -LRB- denotes [
T2323 409-419 NN denotes expression
T2322 404-408 NN denotes gene
T2321 394-403 JJ denotes apoptotic
T2320 385-393 VB denotes regulate
T2319 380-384 RB denotes down
T2318 373-379 CC denotes and/or
T2317 367-372 NN denotes genes
T2316 352-366 JJ denotes anti-apoptotic
T2315 340-351 VB denotes up-regulate
T2314 337-339 TO denotes to
T2313 331-336 VB denotes found
T2312 327-330 VB denotes was
T2311 323-326 CC denotes and
T2310 321-322 -COMMA- denotes ,
T2309 320-321 -RRB- denotes ]
T2308 318-320 CD denotes 27
T2307 317-318 -LRB- denotes [
T2306 308-316 NN denotes melanoma
T2305 304-307 CC denotes and
T2304 296-303 NN denotes cancers
T2303 287-295 NN denotes prostate
T2302 285-286 -COMMA- denotes ,
T2301 278-285 NN denotes cancers
T2300 272-277 NN denotes colon
T2299 262-271 VB denotes including
T2298 254-261 NN denotes cancers
T2297 251-253 IN denotes of
T2296 244-250 NN denotes number
T2295 238-243 JJ denotes great
T2294 236-237 DT denotes a
T2293 233-235 IN denotes in
T2292 223-232 VB denotes described
T2291 218-222 VB denotes been
T2290 214-217 VB denotes has
T2289 208-213 NN denotes NF-κB
T2288 205-207 IN denotes of
T2287 194-204 NN denotes activation
T2286 181-193 JJ denotes Constitutive
T2285 178-179 -RRB- denotes ]
T2284 176-178 CD denotes 26
T2283 175-176 -LRB- denotes [
T2282 163-174 NN denotes development
T2281 156-162 NN denotes cancer
T2280 151-155 IN denotes with
T2279 140-150 VB denotes associated
T2278 132-139 RB denotes closely
T2277 129-131 VB denotes is
T2276 125-128 CC denotes and
T2275 123-124 -COMMA- denotes ,
T2274 111-123 NN denotes inflammation
T2273 107-110 CC denotes and
T2272 93-106 NN denotes proliferation
T2271 88-92 NN denotes cell
T2270 85-87 IN denotes of
T2269 75-84 NN denotes induction
T2268 71-74 DT denotes the
T2267 68-70 IN denotes as
T2266 63-67 RB denotes well
T2265 60-62 RB denotes as
T2264 58-59 -COMMA- denotes ,
T2263 49-58 NN denotes apoptosis
T2262 46-48 IN denotes of
T2261 34-45 NN denotes suppression
T2260 30-33 DT denotes the
T2259 27-29 IN denotes in
T2258 22-26 NN denotes role
T2257 14-21 JJ denotes crucial
T2256 12-13 DT denotes a
T2255 6-11 VB denotes plays
T2254 0-5 NN denotes NF-κB
R1335 T2254 T2255 arg1Of NF-κB,plays
R1336 T2254 T2277 arg1Of NF-κB,is
R1337 T2254 T2279 arg2Of NF-κB,associated
R1338 T2255 T2259 arg1Of plays,in
R1339 T2255 T2276 arg1Of plays,and
R1340 T2258 T2255 arg2Of role,plays
R1341 T2258 T2256 arg1Of role,a
R1342 T2258 T2257 arg1Of role,crucial
R1343 T2261 T2260 arg1Of suppression,the
R1344 T2261 T2262 arg1Of suppression,of
R1345 T2261 T2267 arg1Of suppression,as
R1346 T2263 T2262 arg2Of apoptosis,of
R1347 T2267 T2259 arg2Of as,in
R1348 T2267 T2264 arg1Of as,","
R1349 T2267 T2265 arg1Of as,as
R1350 T2267 T2266 arg1Of as,well
R1351 T2269 T2267 arg2Of induction,as
R1352 T2269 T2268 arg1Of induction,the
R1353 T2269 T2270 arg1Of induction,of
R1354 T2272 T2273 arg1Of proliferation,and
R1355 T2273 T2270 arg2Of and,of
R1356 T2273 T2271 arg1Of and,cell
R1357 T2274 T2273 arg2Of inflammation,and
R1358 T2276 T2275 arg1Of and,","
R1359 T2279 T2276 arg2Of associated,and
R1360 T2279 T2277 arg2Of associated,is
R1361 T2279 T2278 arg1Of associated,closely
R1362 T2279 T2280 arg1Of associated,with
R1363 T2279 T2283 arg1Of associated,[
R1364 T2282 T2280 arg2Of development,with
R1365 T2282 T2281 arg1Of development,cancer
R1366 T2284 T2283 arg2Of 26,[
R1367 T2285 T2283 arg3Of ],[
R1368 T2287 T2286 arg1Of activation,Constitutive
R1369 T2287 T2288 arg1Of activation,of
R1370 T2287 T2290 arg1Of activation,has
R1371 T2287 T2291 arg1Of activation,been
R1372 T2287 T2292 arg2Of activation,described
R1373 T2287 T2312 arg1Of activation,was
R1374 T2287 T2313 arg2Of activation,found
R1375 T2287 T2315 arg1Of activation,up-regulate
R1376 T2287 T2320 arg1Of activation,regulate
R1377 T2289 T2288 arg2Of NF-κB,of
R1378 T2292 T2290 arg2Of described,has
R1379 T2292 T2291 arg2Of described,been
R1380 T2292 T2293 arg1Of described,in
R1381 T2292 T2311 arg1Of described,and
R1382 T2296 T2293 arg2Of number,in
R1383 T2296 T2294 arg1Of number,a
R1384 T2296 T2295 arg1Of number,great
R1385 T2296 T2297 arg1Of number,of
R1386 T2298 T2297 arg2Of cancers,of
R1387 T2298 T2299 arg1Of cancers,including
R1388 T2301 T2300 arg1Of cancers,colon
R1389 T2301 T2302 arg1Of cancers,","
R1390 T2302 T2305 arg1Of ",",and
R1391 T2304 T2302 arg2Of cancers,","
R1392 T2304 T2303 arg1Of cancers,prostate
R1393 T2305 T2299 arg2Of and,including
R1394 T2306 T2305 arg2Of melanoma,and
R1395 T2306 T2307 arg1Of melanoma,[
R1396 T2308 T2307 arg2Of 27,[
R1397 T2309 T2307 arg3Of ],[
R1398 T2311 T2310 arg1Of and,","
R1399 T2311 T2324 arg1Of and,[
R1400 T2313 T2312 arg2Of found,was
R1401 T2323 T2320 arg2Of expression,regulate
R1402 T2323 T2321 arg1Of expression,apoptotic
R1403 T2323 T2322 arg1Of expression,gene
R1404 T2313 T2318 arg1Of found,and/or
R1405 T2315 T2313 arg3Of up-regulate,found
R1406 T2325 T2324 arg2Of 28,[
R1407 T2326 T2324 arg3Of ],[
R1408 T2328 T2329 arg1Of NF-κB,promotes
R1409 T2315 T2314 arg1Of up-regulate,to
R1410 T2329 T2327 arg2Of promotes,Although
R1411 T2317 T2315 arg2Of genes,up-regulate
R1412 T2331 T2329 arg2Of growth,promotes
R1413 T2331 T2330 arg1Of growth,tumor
R1414 T2333 T2334 arg1Of it,is
R1415 T2333 T2335 arg2Of it,required
R1416 T2317 T2316 arg1Of genes,anti-apoptotic
R1417 T2318 T2311 arg2Of and/or,and
R1418 T2335 T2327 arg1Of required,Although
R1419 T2335 T2332 arg1Of required,","
R1420 T2335 T2334 arg2Of required,is
R1421 T2335 T2336 arg1Of required,for
R1422 T2320 T2318 arg2Of regulate,and/or
R1423 T2339 T2336 arg2Of system,for
R1424 T2339 T2337 arg1Of system,the
R1425 T2339 T2338 arg1Of system,immune
R1426 T2339 T2340 modOf system,to
R1427 T2320 T2319 arg1Of regulate,down
R1428 T2423 T2419 arg2Of death,affecting
R1429 T2341 T2340 arg1Of function,to
R1430 T2341 T2342 arg1Of function,normally
R1431 T2341 T2343 arg1Of function,[
R1432 T2344 T2343 arg2Of 29,[
R1433 T2345 T2343 arg3Of ],[
R1434 T2346 T2347 arg1Of Studies,on
R1435 T2346 T2350 arg1Of Studies,demonstrated
R1436 T2349 T2347 arg2Of mice,on
R1437 T2349 T2348 arg1Of mice,c-Rel-deficient
R1438 T2423 T2420 arg1Of death,apoptotic
R1439 T2423 T2421 arg1Of death,cancer
R1440 T2423 T2422 arg1Of death,cell
R1441 T2423 T2424 arg1Of death,","
R1442 T2423 T2425 arg1Of death,(
R1443 T2352 T2353 arg1Of c-Rel,is
R1444 T2352 T2354 arg1Of c-Rel,essential
R1445 T2353 T2350 arg2Of is,demonstrated
R1446 T2353 T2351 arg1Of is,that
R1447 T2353 T2368 arg1Of is,[
R1448 T2354 T2353 arg2Of essential,is
R1449 T2354 T2355 arg1Of essential,for
R1450 T2356 T2357 arg1Of IL-2,","
R1451 T2357 T2359 arg1Of ",",","
R1452 T2358 T2357 arg2Of IL-3,","
R1453 T2359 T2362 arg1Of ",",and
R1454 T2423 T2428 arg1Of death,stimulating
R1455 T2360 T2359 arg2Of GM-CSF,","
R1456 T2423 T2433 arg1Of death,or
R1457 T2423 T2434 arg1Of death,(
R1458 T2362 T2355 arg2Of and,for
R1459 T2362 T2361 arg1Of and,","
R1460 T2362 T2365 arg1Of and,in
R1461 T2423 T2437 arg1Of death,increasing
R1462 T2364 T2362 arg2Of expression,and
R1463 T2364 T2363 arg1Of expression,IFNγ
R1464 T2426 T2425 arg2Of 2,(
R1465 T2367 T2365 arg2Of lymphocytes,in
R1466 T2367 T2366 arg1Of lymphocytes,T
R1467 T2369 T2368 arg2Of 30,[
R1468 T2370 T2368 arg3Of ],[
R1469 T2427 T2425 arg3Of ),(
R1470 T2372 T2371 arg1Of mice,C-Rel-deficient
R1471 T2372 T2374 arg1Of mice,have
R1472 T2432 T2428 arg2Of infiltration,stimulating
R1473 T2374 T2373 arg1Of have,also
R1474 T2374 T2384 arg1Of have,in
R1475 T2377 T2374 arg2Of deficiency,have
R1476 T2377 T2375 arg1Of deficiency,a
R1477 T2377 T2376 arg1Of deficiency,tissue-specific
R1478 T2377 T2378 arg1Of deficiency,of
R1479 T2380 T2379 arg1Of cytokines,various
R1480 T2380 T2381 arg1Of cytokines,and
R1481 T2381 T2378 arg2Of and,of
R1482 T2432 T2429 arg1Of infiltration,tumor
R1483 T2383 T2381 arg2Of factors,and
R1484 T2383 T2382 arg1Of factors,growth
R1485 T2432 T2430 arg1Of infiltration,killing
R1486 T2432 T2431 arg1Of infiltration,lymphocytes
R1487 T2435 T2434 arg2Of 3,(
R1488 T2386 T2385 arg1Of cells,T
R1489 T2386 T2387 arg1Of cells,and
R1490 T2387 T2384 arg2Of and,in
R1491 T2387 T2389 arg1Of and,affecting
R1492 T2388 T2387 arg2Of macrophages,and
R1493 T2389 T2396 arg1Of affecting,in
R1494 T2389 T2399 arg1Of affecting,[
R1495 T2391 T2392 arg1Of innate,and
R1496 T2436 T2434 arg3Of ),(
R1497 T2392 T2390 arg1Of and,both
R1498 T2393 T2392 arg2Of humoral,and
R1499 T2395 T2389 arg2Of responses,affecting
R1500 T2395 T2391 arg1Of responses,innate
R1501 T2395 T2393 arg1Of responses,humoral
R1502 T2395 T2394 arg1Of responses,immune
R1503 T2398 T2396 arg2Of host,in
R1504 T2398 T2397 arg1Of host,the
R1505 T2439 T2437 arg2Of production,increasing
R1506 T2400 T2399 arg2Of 31,[
R1507 T2401 T2399 arg3Of ],[
R1508 T2439 T2438 arg1Of production,the
R1509 T2404 T2405 arg1Of NF-κB,can
R1510 T2404 T2406 arg1Of NF-κB,be
R1511 T2404 T2408 arg2Of NF-κB,targeted
R1512 T2404 T2410 arg1Of NF-κB,prevent
R1513 T2439 T2440 arg1Of production,of
R1514 T2443 T2440 arg2Of lymphokines,of
R1515 T2404 T2419 arg1Of NF-κB,affecting
R1516 T2443 T2441 arg1Of lymphokines,tumor
R1517 T2408 T2402 arg1Of targeted,Therefore
R1518 T2408 T2403 arg1Of targeted,","
R1519 T2408 T2405 arg2Of targeted,can
R1520 T2408 T2406 arg2Of targeted,be
R1521 T2408 T2407 arg1Of targeted,specially
R1522 T2410 T2408 arg3Of prevent,targeted
R1523 T2410 T2409 arg1Of prevent,to
R1524 T2410 T2414 arg1Of prevent,by
R1525 T2443 T2442 arg1Of lymphokines,killing
R1526 T2444 T2445 arg1Of Activation,of
R1527 T2413 T2410 arg2Of growth,prevent
R1528 T2413 T2411 arg1Of growth,cancer
R1529 T2413 T2412 arg1Of growth,cell
R1530 T2444 T2447 arg1Of Activation,is
R1531 T2444 T2448 arg1Of Activation,important
R1532 T2416 T2415 arg1Of 1,(
R1533 T2416 T2417 arg1Of 1,)
R1534 T2446 T2445 arg2Of NF-κB,of
R1535 T2419 T2414 arg2Of affecting,by
R1536 T2419 T2416 arg1Of affecting,1
R1537 T2419 T2418 arg1Of affecting,directly
R1538 T2448 T2447 arg2Of important,is
R1539 T2448 T2449 arg1Of important,in
R1540 T2451 T2449 arg2Of regulation,in
R1541 T2451 T2450 arg1Of regulation,the
R1542 T2451 T2452 arg1Of regulation,of
R1543 T2455 T2456 arg1Of growth,and
R1544 T2519 T2515 arg2Of development,in
R1545 T2519 T2516 arg1Of development,CCR5
R1546 T2519 T2517 arg2Of development,mediated
R1547 T2519 T2518 arg1Of development,tumor
R1554 T2456 T2452 arg2Of and,of
R1557 T2456 T2453 arg1Of and,CCR-mediated
R1558 T2456 T2454 arg1Of and,tumor
R1563 T2457 T2456 arg2Of metastasis,and
R1569 T2458 T2459 arg1Of It,was
R1572 T2458 T2460 arg2Of It,reported
R1575 T2460 T2459 arg2Of reported,was
R1582 T2462 T2463 arg1Of inhibition,of
R1585 T2462 T2465 arg1Of inhibition,by
R1586 T2462 T2470 arg1Of inhibition,induces
R1587 T2464 T2463 arg2Of NF-κB,of
R1595 T2466 T2465 arg2Of dehydroxymethyl-epoxyquinomicin,by
R1602 T2466 T2467 arg1Of dehydroxymethyl-epoxyquinomicin,(
R1603 T2468 T2467 arg2Of DHMEQ,(
R1609 T2469 T2467 arg3Of ),(
R1614 T2470 T2460 arg3Of induces,reported
R1616 T2470 T2461 arg1Of induces,that
R1618 T2470 T2477 arg1Of induces,by
R1619 T2470 T2482 arg1Of induces,[
R1624 T2472 T2470 arg2Of death,induces
R1629 T2472 T2471 arg1Of death,cell
R1630 T2472 T2473 arg1Of death,of
R1631 T2476 T2473 arg2Of lymphoma,of
R1641 T2476 T2474 arg1Of lymphoma,primary
R1642 T2476 T2475 arg1Of lymphoma,effusion
R1648 T2478 T2477 arg2Of inhibition,by
R1656 T2478 T2479 arg1Of inhibition,of
R1657 T2481 T2479 arg2Of expression,of
R1664 T2481 T2480 arg1Of expression,CCR5
R1672 T2483 T2482 arg2Of 32,[
R1673 T2484 T2482 arg3Of ],[
R1675 T2485 T2486 arg1Of Activation,of
R1677 T2485 T2489 arg1Of Activation,increases
R1679 T2487 T2486 arg2Of NF-κB,of
R1688 T2489 T2488 arg1Of increases,also
R1692 T2493 T2490 arg1Of motility,CCL5-mediated
R1705 T2493 T2491 arg1Of motility,oral
R1707 T2493 T2492 arg1Of motility,cancer
R1709 T2493 T2494 arg1Of motility,(
R1711 T2493 T2497 arg1Of motility,and
R1712 T2495 T2494 arg2Of 5,(
R1718 T2496 T2494 arg3Of ),(
R1724 T2497 T2489 arg2Of and,increases
R1728 T2499 T2497 arg2Of metastasis,and
R1735 T2499 T2498 arg1Of metastasis,lung
R1739 T2499 T2500 arg1Of metastasis,[
R1742 T2501 T2500 arg2Of 33,[
R1749 T2502 T2500 arg3Of ],[
R1755 T2506 T2503 arg1Of is,Thus
R1768 T2506 T2504 arg1Of is,","
R1769 T2507 T2506 arg2Of possible,is
R1774 T2509 T2510 arg1Of inhibition,of
R1779 T2509 T2512 arg1Of inhibition,could
R1780 T2509 T2513 arg1Of inhibition,be
R1783 T2509 T2514 arg2Of inhibition,involved
R1784 T2511 T2510 arg2Of NF-κB,of
R1792 T2514 T2505 arg1Of involved,it
R1799 T2514 T2506 arg1Of involved,is
R1801 T2514 T2507 arg1Of involved,possible
R1802 T2514 T2508 arg1Of involved,that
R1803 T2514 T2512 arg2Of involved,could
R1804 T2514 T2513 arg2Of involved,be
R1805 T2514 T2515 arg1Of involved,in

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T1550 1540-1544 Protein denotes CCR5
T1549 1408-1412 Protein denotes CCL5
T1548 1351-1355 Protein denotes CCR5
T1547 613-619 Protein denotes GM-CSF
T1546 607-611 Protein denotes IL-3
T1545 601-605 Protein denotes IL-2
T1544 578-583 Protein denotes c-Rel
T1543 539-544 Protein denotes c-Rel

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T2752 616-619 http://www.uniprot.org/uniprot/P04141 denotes CSF
T2751 613-619 http://www.uniprot.org/uniprot/P04141 denotes GM-CSF
T2750 601-605 http://www.uniprot.org/uniprot/P60568 denotes IL-2
T2749 578-583 http://www.uniprot.org/uniprot/Q04864 denotes c-Rel
T2748 539-544 http://www.uniprot.org/uniprot/Q04864 denotes c-Rel
T2730 1540-1544 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T2729 1351-1355 http://www.uniprot.org/uniprot/P51681 denotes CCR5

UBERON-AE

Id Subject Object Predicate Lexical cue
T1403 697-703 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
T1402 487-500 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T1401 272-277 http://purl.obolibrary.org/obo/UBERON_0001155 denotes colon
T1399 1451-1455 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung

GO-BP

Id Subject Object Predicate Lexical cue
T1592 1560-1571 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T1591 163-174 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T1583 111-123 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T1581 1179-1185 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T1580 926-932 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T1579 749-755 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T1578 456-462 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T1569 921-932 http://purl.obolibrary.org/obo/GO_0016049 denotes cell growth
T1621 1160-1163 http://purl.obolibrary.org/obo/GO_0043880 denotes CCR
T1619 1146-1156 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T1618 1299-1304 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T1617 981-986 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T1616 1294-1304 http://purl.obolibrary.org/obo/GO_0008219 denotes cell death
T1615 976-986 http://purl.obolibrary.org/obo/GO_0008219 denotes cell death
T1614 832-853 http://purl.obolibrary.org/obo/GO_0075136 denotes responses in the host
T1613 825-853 http://purl.obolibrary.org/obo/GO_0052572 denotes immune responses in the host
T1612 817-841 http://purl.obolibrary.org/obo/GO_0002921 denotes humoral immune responses
T1611 817-841 http://purl.obolibrary.org/obo/GO_0002920 denotes humoral immune responses
T1610 817-841 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune responses
T1609 817-841 http://purl.obolibrary.org/obo/GO_0002922 denotes humoral immune responses
T1607 404-419 http://purl.obolibrary.org/obo/GO_0010467 denotes gene expression
T1604 194-213 http://purl.obolibrary.org/obo/GO_0051092 denotes activation of NF-κB
T1603 88-106 http://purl.obolibrary.org/obo/GO_0008283 denotes cell proliferation
T1602 49-58 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T1601 49-58 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T1600 825-841 http://purl.obolibrary.org/obo/GO_0006955 denotes immune responses

GO-MF

Id Subject Object Predicate Lexical cue
T1669 1160-1163 http://purl.obolibrary.org/obo/GO_0043880 denotes CCR
T1668 607-611 http://purl.obolibrary.org/obo/GO_0005135 denotes IL-3
T1667 601-605 http://purl.obolibrary.org/obo/GO_0005134 denotes IL-2

GO-CC

Id Subject Object Predicate Lexical cue
T1644 849-853 http://purl.obolibrary.org/obo/GO_0018995 denotes host
T1642 1294-1298 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T1641 976-980 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T1640 921-925 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T1639 88-92 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

sentences

Id Subject Object Predicate Lexical cue
T1425 426-527 Sentence denotes Although NF-κB promotes tumor growth, it is required for the immune system to function normally [29].
T1424 181-425 Sentence denotes Constitutive activation of NF-κB has been described in a great number of cancers including colon cancers, prostate cancers and melanoma [27], and was found to up-regulate anti-apoptotic genes and/or down regulate apoptotic gene expression [28].
T1423 0-180 Sentence denotes NF-κB plays a crucial role in the suppression of apoptosis, as well as the induction of cell proliferation and inflammation, and is closely associated with cancer development [26].
T1430 1202-1372 Sentence denotes It was reported that inhibition of NF-κB by dehydroxymethyl-epoxyquinomicin (DHMEQ) induces cell death of primary effusion lymphoma by inhibition of CCR5 expression [32].
T1429 1106-1201 Sentence denotes Activation of NF-κB is important in the regulation of CCR-mediated tumor growth and metastasis.
T1428 860-1105 Sentence denotes Therefore, NF-κB can be specially targeted to prevent cancer cell growth by (1) directly affecting apoptotic cancer cell death, (2) stimulating tumor killing lymphocytes infiltration or (3) increasing the production of tumor killing lymphokines.
T1427 664-859 Sentence denotes C-Rel-deficient mice also have a tissue-specific deficiency of various cytokines and growth factors in T cells and macrophages affecting both innate and humoral immune responses in the host [31].
T1426 528-663 Sentence denotes Studies on c-Rel-deficient mice demonstrated that c-Rel is essential for IL-2, IL-3, GM-CSF, and IFNγ expression in T lymphocytes [30].
T1432 1473-1572 Sentence denotes Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.
T1431 1373-1472 Sentence denotes Activation of NF-κB also increases CCL5-mediated oral cancer motility (5) and lung metastasis [33].
T32 0-180 Sentence denotes NF-κB plays a crucial role in the suppression of apoptosis, as well as the induction of cell proliferation and inflammation, and is closely associated with cancer development [26].
T33 181-425 Sentence denotes Constitutive activation of NF-κB has been described in a great number of cancers including colon cancers, prostate cancers and melanoma [27], and was found to up-regulate anti-apoptotic genes and/or down regulate apoptotic gene expression [28].
T34 426-527 Sentence denotes Although NF-κB promotes tumor growth, it is required for the immune system to function normally [29].
T35 528-663 Sentence denotes Studies on c-Rel-deficient mice demonstrated that c-Rel is essential for IL-2, IL-3, GM-CSF, and IFNγ expression in T lymphocytes [30].
T36 664-859 Sentence denotes C-Rel-deficient mice also have a tissue-specific deficiency of various cytokines and growth factors in T cells and macrophages affecting both innate and humoral immune responses in the host [31].
T37 860-1105 Sentence denotes Therefore, NF-κB can be specially targeted to prevent cancer cell growth by (1) directly affecting apoptotic cancer cell death, (2) stimulating tumor killing lymphocytes infiltration or (3) increasing the production of tumor killing lymphokines.
T38 1106-1201 Sentence denotes Activation of NF-κB is important in the regulation of CCR-mediated tumor growth and metastasis.
T39 1202-1372 Sentence denotes It was reported that inhibition of NF-κB by dehydroxymethyl-epoxyquinomicin (DHMEQ) induces cell death of primary effusion lymphoma by inhibition of CCR5 expression [32].
T40 1373-1472 Sentence denotes Activation of NF-κB also increases CCL5-mediated oral cancer motility (5) and lung metastasis [33].
T41 1473-1572 Sentence denotes Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.

simple1

Id Subject Object Predicate Lexical cue
T1704 1540-1544 Protein denotes CCR5
T1703 1408-1412 Protein denotes CCL5
T1702 1351-1355 Protein denotes CCR5
T1701 613-619 Protein denotes GM-CSF
T1700 607-611 Protein denotes IL-3
T1699 601-605 Protein denotes IL-2
T1698 578-583 Protein denotes c-Rel
T1697 539-544 Protein denotes c-Rel

DLUT931

Id Subject Object Predicate Lexical cue
T2821 1286-1293 Positive_regulation denotes induces
T2820 1337-1347 Negative_regulation denotes inhibition
T2819 1356-1366 Gene_expression denotes expression
T2818 630-640 Gene_expression denotes expression
T2817 587-596 Positive_regulation denotes essential
T2816 545-554 Negative_regulation denotes deficient
T2788 1540-1544 Protein denotes CCR5
T2787 1408-1412 Protein denotes CCL5
T2786 1351-1355 Protein denotes CCR5
T2785 613-619 Protein denotes GM-CSF
T2784 607-611 Protein denotes IL-3
T2783 601-605 Protein denotes IL-2
T2782 578-583 Protein denotes c-Rel
T2781 539-544 Protein denotes c-Rel
R1829 T2781 T2816 themeOf c-Rel,deficient
R1833 T2782 T2817 causeOf c-Rel,essential
R1834 T2782 T2817 causeOf c-Rel,essential
R1835 T2782 T2817 causeOf c-Rel,essential
R1837 T2783 T2817 themeOf IL-2,essential
R1838 T2783 T2818 themeOf IL-2,expression
R1839 T2784 T2817 themeOf IL-3,essential
R1840 T2784 T2818 themeOf IL-3,expression
R1842 T2785 T2817 causeOf GM-CSF,essential
R1843 T2785 T2817 causeOf GM-CSF,essential
R1844 T2785 T2818 themeOf GM-CSF,expression
R1845 T2785 T2817 causeOf GM-CSF,essential
R1846 T2785 T2817 causeOf GM-CSF,essential
R1847 T2785 T2817 causeOf GM-CSF,essential
R1848 T2786 T2819 themeOf CCR5,expression
R1855 T2818 T2817 themeOf expression,essential
R1858 T2818 T2817 themeOf expression,essential
R1859 T2818 T2817 themeOf expression,essential
R1860 T2818 T2817 themeOf expression,essential
R1861 T2818 T2817 themeOf expression,essential
R1862 T2818 T2817 themeOf expression,essential
R1863 T2819 T2820 themeOf expression,inhibition
R1865 T2820 T2821 themeOf inhibition,induces

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T4361 1499-1518 Negative_regulation denotes inhibition of NF-κB
T4360 1061-1104 Gene_expression denotes the production of tumor killing lymphokines
T4357 1373-1392 Positive_regulation denotes Activation of NF-κB
T4350 1046-1104 Positive_regulation denotes (3) increasing the production of tumor killing lymphokines
T4347 1337-1371 Negative_regulation denotes inhibition of CCR5 expression [32]
T4346 1537-1571 Regulation denotes in CCR5 mediated tumor development
T4344 1106-1125 Positive_regulation denotes Activation of NF-κB
T4343 1348-1366 Gene_expression denotes of CCR5 expression
T4342 625-640 Gene_expression denotes IFNγ expression
T4339 1218-1285 Negative_regulation denotes that inhibition of NF-κB by dehydroxymethyl-epoxyquinomicin (DHMEQ)
T4337 0-5 Protein denotes NF-κB
T4336 1117-1125 Protein denotes of NF-κB
T4335 727-744 Protein denotes various cytokines
T4334 1243-1285 Entity denotes by dehydroxymethyl-epoxyquinomicin (DHMEQ)
T4331 959-1029 Entity denotes apoptotic cancer cell death, (2) stimulating tumor killing lymphocytes
T4330 1537-1571 Protein denotes in CCR5 mediated tumor development
T4323 779-790 Entity denotes macrophages
T4320 1234-1242 Protein denotes of NF-κB
T4313 1384-1392 Protein denotes of NF-κB
T4303 1408-1421 Protein denotes CCL5-mediated
T4300 1510-1518 Protein denotes of NF-κB
T4297 871-876 Protein denotes NF-κB
T4295 352-372 Protein denotes anti-apoptotic genes
T4288 1351-1355 Protein denotes CCR5
T4287 435-440 Protein denotes NF-κB
T4284 181-213 Protein denotes Constitutive activation of NF-κB
T4283 664-684 Protein denotes C-Rel-deficient mice
T4279 625-629 Protein denotes IFNγ
T4275 578-583 Protein denotes c-Rel
T4272 613-619 Protein denotes GM-CSF
T4270 601-605 Protein denotes IL-2
T4268 767-774 Entity denotes T cells
T4251 536-544 Protein denotes on c-Rel
T4250 644-662 Entity denotes T lymphocytes [30]
T4243 1076-1104 Protein denotes of tumor killing lymphokines
T4239 1046-1104 Entity denotes (3) increasing the production of tumor killing lymphokines
T4233 607-611 Protein denotes IL-3
R3038 T4239 T4350 causeOf (3) increasing the production of tumor killing lymphokines,(3) increasing the production of tumor killing lymphokines
R3041 T4243 T4360 themeOf of tumor killing lymphokines,the production of tumor killing lymphokines
R3051 T4279 T4342 themeOf IFNγ,IFNγ expression
R3054 T4288 T4343 themeOf CCR5,of CCR5 expression
R3058 T4300 T4361 themeOf of NF-κB,inhibition of NF-κB
R3059 T4313 T4357 themeOf of NF-κB,Activation of NF-κB
R3060 T4320 T4339 themeOf of NF-κB,that inhibition of NF-κB by dehydroxymethyl-epoxyquinomicin (DHMEQ)
R3062 T4330 T4346 themeOf in CCR5 mediated tumor development,in CCR5 mediated tumor development
R3064 T4334 T4339 causeOf by dehydroxymethyl-epoxyquinomicin (DHMEQ),that inhibition of NF-κB by dehydroxymethyl-epoxyquinomicin (DHMEQ)
R3065 T4336 T4344 themeOf of NF-κB,Activation of NF-κB
R3066 T4343 T4347 themeOf of CCR5 expression,inhibition of CCR5 expression [32]
R3069 T4360 T4350 themeOf the production of tumor killing lymphokines,(3) increasing the production of tumor killing lymphokines

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T3903 1356-1366 NN denotes expression
T3852 1030-1042 NN denotes infiltration
T3851 1018-1029 NNS denotes lymphocytes
T3850 1010-1017 VBG denotes killing
T3849 1004-1009 NN denotes tumor
T3848 992-1003 VBG denotes stimulating
T3847 990-991 -RRB- denotes )
T3846 989-990 LS denotes 2
T3845 988-989 -LRB- denotes (
T3844 986-987 , denotes ,
T3843 981-986 NN denotes death
T3842 976-980 NN denotes cell
T3796 713-723 NN denotes deficiency
T3795 697-712 JJ denotes tissue-specific
T3794 695-696 DT denotes a
T3793 690-694 VBP denotes have
T3792 685-689 RB denotes also
T3791 680-684 NNS denotes mice
T3790 664-679 JJ denotes C-Rel-deficient
T3789 662-663 . denotes .
T3788 661-662 NNP denotes ]
T3787 659-661 CD denotes 30
T3786 658-659 NNP denotes [
T3785 646-657 NNS denotes lymphocytes
T3784 644-645 NNP denotes T
T3783 641-643 IN denotes in
T3782 630-640 NN denotes expression
T3781 625-629 NNP denotes IFNγ
T3780 621-624 CC denotes and
T3779 619-620 , denotes ,
T3778 613-619 NNP denotes GM-CSF
T3777 611-612 , denotes ,
T3776 607-611 NNP denotes IL-3
T3744 426-434 IN denotes Although
T3743 424-425 . denotes .
T3742 423-424 NNP denotes ]
T3741 421-423 CD denotes 28
T3740 420-421 NNP denotes [
T3739 409-419 NN denotes expression
T3738 404-408 NN denotes gene
T3737 394-403 JJ denotes apoptotic
T3736 385-393 VB denotes regulate
T3735 380-384 RB denotes down
T3734 373-379 CC denotes and/or
T3733 367-372 NNS denotes genes
T3732 352-366 JJ denotes anti-apoptotic
T3731 340-351 VB denotes up-regulate
T3730 337-339 TO denotes to
T3729 331-336 VBN denotes found
T3728 327-330 VBD denotes was
T3727 323-326 CC denotes and
T3726 321-322 , denotes ,
T3725 320-321 NNP denotes ]
T3724 318-320 CD denotes 27
T3723 317-318 NNP denotes [
T3722 308-316 NN denotes melanoma
T3721 304-307 CC denotes and
T3720 296-303 NNS denotes cancers
T3719 287-295 NN denotes prostate
T3718 285-286 , denotes ,
T3717 278-285 NNS denotes cancers
T3716 272-277 NN denotes colon
T3715 262-271 VBG denotes including
T3714 254-261 NNS denotes cancers
T3713 251-253 IN denotes of
T3712 244-250 NN denotes number
T3711 238-243 JJ denotes great
T3710 236-237 DT denotes a
T3709 233-235 IN denotes in
T3708 223-232 VBN denotes described
T3707 218-222 VBN denotes been
T3706 214-217 VBZ denotes has
T3705 208-213 NNP denotes NF-κB
T3704 205-207 IN denotes of
T3703 194-204 NN denotes activation
T3702 181-193 JJ denotes Constitutive
T3701 179-180 . denotes .
T3700 178-179 NNP denotes ]
T3775 605-606 , denotes ,
T3774 601-605 NNP denotes IL-2
T3773 597-600 IN denotes for
T3772 587-596 JJ denotes essential
T3771 584-586 VBZ denotes is
T3770 578-583 NNP denotes c-Rel
T3769 573-577 IN denotes that
T3768 560-572 VBD denotes demonstrated
T3767 555-559 NNS denotes mice
T3766 539-554 JJ denotes c-Rel-deficient
T3765 536-538 IN denotes on
T3764 528-535 NNS denotes Studies
T3763 526-527 . denotes .
T3762 525-526 NN denotes ]
T3761 523-525 CD denotes 29
T3760 522-523 JJ denotes [
T3759 513-521 RB denotes normally
T3758 504-512 VB denotes function
T3757 501-503 TO denotes to
T3756 494-500 NN denotes system
T3755 487-493 JJ denotes immune
T3754 483-486 DT denotes the
T3753 479-482 IN denotes for
T3752 470-478 VBN denotes required
T3751 467-469 VBZ denotes is
T3750 464-466 PRP denotes it
T3749 462-463 , denotes ,
T3748 456-462 NN denotes growth
T3747 450-455 NN denotes tumor
T3746 441-449 VBZ denotes promotes
T3745 435-440 JJ denotes NF-κB
T3699 176-178 CD denotes 26
T3698 175-176 NNP denotes [
T3697 163-174 NN denotes development
T3696 156-162 NN denotes cancer
T3695 151-155 IN denotes with
T3694 140-150 VBN denotes associated
T3693 132-139 RB denotes closely
T3692 129-131 VBZ denotes is
T3691 125-128 CC denotes and
T3690 123-124 , denotes ,
T3689 111-123 NN denotes inflammation
T3688 107-110 CC denotes and
T3687 93-106 NN denotes proliferation
T3686 88-92 NN denotes cell
T3685 85-87 IN denotes of
T3684 75-84 NN denotes induction
T3683 71-74 DT denotes the
T3682 68-70 IN denotes as
T3681 63-67 RB denotes well
T3680 60-62 RB denotes as
T3679 58-59 , denotes ,
T3678 49-58 NN denotes apoptosis
T3677 46-48 IN denotes of
T3676 34-45 NN denotes suppression
T3675 30-33 DT denotes the
T3674 27-29 IN denotes in
T3673 22-26 NN denotes role
T3672 14-21 JJ denotes crucial
T3671 12-13 DT denotes a
T3670 6-11 NNS denotes plays
T3669 0-5 JJ denotes NF-κB
T3797 724-726 IN denotes of
T3841 969-975 NN denotes cancer
T3840 959-968 JJ denotes apoptotic
T3839 949-958 VBG denotes affecting
T3838 940-948 RB denotes directly
T3837 938-939 -RRB- denotes )
T3836 937-938 CD denotes 1
T3835 936-937 -LRB- denotes (
T3834 933-935 IN denotes by
T3833 926-932 NN denotes growth
T3832 921-925 NN denotes cell
T3831 914-920 NN denotes cancer
T3830 906-913 VB denotes prevent
T3829 903-905 TO denotes to
T3828 894-902 VBN denotes targeted
T3827 884-893 RB denotes specially
T3826 881-883 VB denotes be
T3825 877-880 MD denotes can
T3824 871-876 NNP denotes NF-κB
T3823 869-870 , denotes ,
T3822 860-869 RB denotes Therefore
T3821 858-859 . denotes .
T3820 857-858 NNP denotes ]
T3819 855-857 CD denotes 31
T3818 854-855 NNP denotes [
T3817 849-853 NN denotes host
T3816 845-848 DT denotes the
T3815 842-844 IN denotes in
T3814 832-841 NNS denotes responses
T3813 825-831 JJ denotes immune
T3812 817-824 JJ denotes humoral
T3811 813-816 CC denotes and
T3810 806-812 NN denotes innate
T3809 801-805 DT denotes both
T3808 791-800 VBG denotes affecting
T3807 779-790 NNS denotes macrophages
T3806 775-778 CC denotes and
T3805 769-774 NNS denotes cells
T3804 767-768 NNP denotes T
T3803 764-766 IN denotes in
T3802 756-763 NNS denotes factors
T3801 749-755 NN denotes growth
T3800 745-748 CC denotes and
T3799 735-744 NNS denotes cytokines
T3798 727-734 JJ denotes various
T3902 1351-1355 CD denotes CCR5
T3901 1348-1350 IN denotes of
T3900 1337-1347 NN denotes inhibition
T3899 1334-1336 IN denotes by
T3898 1325-1333 NN denotes lymphoma
T3897 1316-1324 NN denotes effusion
T3896 1308-1315 JJ denotes primary
T3895 1305-1307 IN denotes of
T3894 1299-1304 NN denotes death
T3893 1294-1298 NN denotes cell
T3892 1286-1293 VBZ denotes induces
T3891 1284-1285 -RRB- denotes )
T3890 1279-1284 NNP denotes DHMEQ
T3889 1278-1279 -LRB- denotes (
T3888 1246-1277 NN denotes dehydroxymethyl-epoxyquinomicin
T3887 1243-1245 IN denotes by
T3886 1237-1242 NN denotes NF-κB
T3885 1234-1236 IN denotes of
T3884 1223-1233 NN denotes inhibition
T3883 1218-1222 IN denotes that
T3882 1209-1217 VBN denotes reported
T3881 1205-1208 VBD denotes was
T3880 1202-1204 PRP denotes It
T3879 1200-1201 . denotes .
T3878 1190-1200 NN denotes metastasis
T3877 1186-1189 CC denotes and
T3876 1179-1185 NN denotes growth
T3875 1173-1178 NN denotes tumor
T3874 1160-1172 JJ denotes CCR-mediated
T3873 1157-1159 IN denotes of
T3872 1146-1156 NN denotes regulation
T3871 1142-1145 DT denotes the
T3870 1139-1141 IN denotes in
T3869 1129-1138 JJ denotes important
T3868 1126-1128 VBZ denotes is
T3867 1120-1125 NNP denotes NF-κB
T3866 1117-1119 IN denotes of
T3865 1106-1116 NNP denotes Activation
T3864 1104-1105 . denotes .
T3863 1093-1104 NNS denotes lymphokines
T3862 1085-1092 VBG denotes killing
T3861 1079-1084 NN denotes tumor
T3860 1076-1078 IN denotes of
T3859 1065-1075 NN denotes production
T3858 1061-1064 DT denotes the
T3857 1050-1060 VBG denotes increasing
T3856 1048-1049 -RRB- denotes )
T3855 1047-1048 LS denotes 3
T3854 1046-1047 -LRB- denotes (
T3853 1043-1045 CC denotes or
T3944 1571-1572 . denotes .
T3943 1560-1571 NN denotes development
T3942 1554-1559 NN denotes tumor
T3941 1545-1553 VBD denotes mediated
T3940 1540-1544 NNP denotes CCR5
T3939 1537-1539 IN denotes in
T3938 1528-1536 VBN denotes involved
T3937 1525-1527 VB denotes be
T3936 1519-1524 MD denotes could
T3935 1513-1518 NN denotes NF-κB
T3934 1510-1512 IN denotes of
T3933 1499-1509 NN denotes inhibition
T3932 1494-1498 IN denotes that
T3931 1485-1493 JJ denotes possible
T3930 1482-1484 VBZ denotes is
T3929 1479-1481 PRP denotes it
T3928 1477-1478 , denotes ,
T3927 1473-1477 RB denotes Thus
T3926 1471-1472 . denotes .
T3925 1470-1471 NNP denotes ]
T3924 1468-1470 CD denotes 33
T3923 1467-1468 NNP denotes [
T3922 1456-1466 NN denotes metastasis
T3921 1451-1455 NN denotes lung
T3920 1447-1450 CC denotes and
T3919 1445-1446 -RRB- denotes )
T3918 1444-1445 CD denotes 5
T3917 1443-1444 -LRB- denotes (
T3916 1434-1442 NN denotes motility
T3915 1427-1433 NN denotes cancer
T3914 1422-1426 JJ denotes oral
T3913 1408-1421 JJ denotes CCL5-mediated
T3912 1398-1407 VBZ denotes increases
T3911 1393-1397 RB denotes also
T3910 1387-1392 NNP denotes NF-κB
T3909 1384-1386 IN denotes of
T3908 1373-1383 NNP denotes Activation
T3907 1371-1372 . denotes .
T3906 1370-1371 NNP denotes ]
T3905 1368-1370 CD denotes 32
T3904 1367-1368 NNP denotes [
R2502 T3669 T3670 amod NF-κB,plays
R2503 T3670 T3694 nsubjpass plays,associated
R2505 T3671 T3673 det a,role
R2506 T3672 T3673 amod crucial,role
R2507 T3673 T3670 dobj role,plays
R2508 T3674 T3673 prep in,role
R2509 T3675 T3676 det the,suppression
R2510 T3676 T3674 pobj suppression,in
R2511 T3677 T3676 prep of,suppression
R2513 T3678 T3677 pobj apoptosis,of
R2514 T3679 T3673 punct ",",role
R2515 T3680 T3682 advmod as,as
R2516 T3681 T3682 advmod well,as
R2518 T3682 T3673 cc as,role
R2519 T3683 T3684 det the,induction
R2520 T3684 T3673 conj induction,role
R2522 T3685 T3684 prep of,induction
R2523 T3686 T3687 compound cell,proliferation
R2524 T3687 T3685 pobj proliferation,of
R2526 T3688 T3687 cc and,proliferation
R2527 T3689 T3687 conj inflammation,proliferation
R2528 T3690 T3670 punct ",",plays
R2530 T3691 T3670 cc and,plays
R2531 T3692 T3694 auxpass is,associated
R2532 T3693 T3694 advmod closely,associated
R2534 T3694 T3694 ROOT associated,associated
R2535 T3695 T3694 prep with,associated
R2536 T3696 T3697 compound cancer,development
R2538 T3697 T3695 pobj development,with
R2539 T3698 T3700 nmod [,]
R2540 T3699 T3700 nummod 26,]
R2543 T3700 T3694 npadvmod ],associated
R2545 T3701 T3694 punct .,associated
R2546 T3702 T3703 amod Constitutive,activation
R2548 T3703 T3708 nsubjpass activation,described
R2549 T3704 T3703 prep of,activation
R2550 T3705 T3704 pobj NF-κB,of
R2552 T3706 T3708 aux has,described
R2553 T3707 T3708 auxpass been,described
R2554 T3708 T3708 ROOT described,described
R2555 T3709 T3708 prep in,described
R2556 T3710 T3712 det a,number
R2557 T3711 T3712 amod great,number
R2559 T3712 T3709 pobj number,in
R2560 T3713 T3712 prep of,number
R2561 T3714 T3713 pobj cancers,of
R2562 T3715 T3714 prep including,cancers
R2564 T3716 T3717 compound colon,cancers
R2565 T3717 T3715 pobj cancers,including
R2566 T3718 T3717 punct ",",cancers
R2568 T3719 T3720 compound prostate,cancers
R2569 T3720 T3717 conj cancers,cancers
R2570 T3721 T3720 cc and,cancers
R2572 T3722 T3720 conj melanoma,cancers
R2573 T3723 T3725 nmod [,]
R2574 T3724 T3725 nummod 27,]
R2576 T3725 T3717 appos ],cancers
R2577 T3726 T3725 punct ",",]
R2578 T3727 T3708 cc and,described
R2579 T3797 T3796 prep of,deficiency
R2580 T3798 T3799 amod various,cytokines
R2581 T3728 T3729 auxpass was,found
R2582 T3729 T3708 conj found,described
R2583 T3799 T3797 pobj cytokines,of
R2584 T3730 T3731 aux to,up-regulate
R2585 T3731 T3729 advcl up-regulate,found
R2586 T3732 T3733 compound anti-apoptotic,genes
R2587 T3800 T3799 cc and,cytokines
R2588 T3733 T3731 dobj genes,up-regulate
R2589 T3734 T3731 cc and/or,up-regulate
R2590 T3735 T3736 advmod down,regulate
R2591 T3801 T3802 compound growth,factors
R2592 T3736 T3731 conj regulate,up-regulate
R2593 T3737 T3739 amod apoptotic,expression
R2594 T3802 T3799 conj factors,cytokines
R2595 T3738 T3739 compound gene,expression
R2596 T3739 T3736 dobj expression,regulate
R2597 T3740 T3742 nmod [,]
R2598 T3803 T3799 prep in,cytokines
R2599 T3741 T3742 nummod 28,]
R2600 T3742 T3739 appos ],expression
R2601 T3804 T3805 compound T,cells
R2602 T3743 T3708 punct .,described
R2603 T3744 T3746 mark Although,promotes
R2604 T3745 T3746 nsubj NF-κB,promotes
R2605 T3746 T3752 advcl promotes,required
R2606 T3747 T3748 compound tumor,growth
R2607 T3748 T3746 dobj growth,promotes
R2608 T3749 T3752 punct ",",required
R2609 T3805 T3803 pobj cells,in
R2610 T3750 T3752 nsubjpass it,required
R2611 T3751 T3752 auxpass is,required
R2612 T3752 T3752 ROOT required,required
R2613 T3753 T3752 prep for,required
R2614 T3806 T3805 cc and,cells
R2615 T3754 T3756 det the,system
R2616 T3755 T3756 amod immune,system
R2617 T3756 T3753 pobj system,for
R2618 T3807 T3805 conj macrophages,cells
R2619 T3757 T3758 aux to,function
R2620 T3758 T3752 advcl function,required
R2621 T3759 T3760 advmod normally,[
R2622 T3760 T3762 amod [,]
R2623 T3808 T3796 acl affecting,deficiency
R2624 T3761 T3762 nummod 29,]
R2625 T3762 T3758 dobj ],function
R2626 T3763 T3752 punct .,required
R2627 T3809 T3810 preconj both,innate
R2628 T3764 T3768 nsubj Studies,demonstrated
R2629 T3765 T3764 prep on,Studies
R2630 T3766 T3767 amod c-Rel-deficient,mice
R2631 T3767 T3765 pobj mice,on
R2632 T3810 T3814 amod innate,responses
R2633 T3768 T3768 ROOT demonstrated,demonstrated
R2634 T3769 T3771 mark that,is
R2635 T3770 T3771 nsubj c-Rel,is
R2636 T3811 T3810 cc and,innate
R2637 T3771 T3768 ccomp is,demonstrated
R2638 T3772 T3771 acomp essential,is
R2639 T3773 T3771 prep for,is
R2640 T3812 T3814 amod humoral,responses
R2641 T3774 T3773 pobj IL-2,for
R2642 T3775 T3774 punct ",",IL-2
R2643 T3776 T3774 conj IL-3,IL-2
R2644 T3777 T3776 punct ",",IL-3
R2645 T3813 T3814 amod immune,responses
R2646 T3778 T3776 conj GM-CSF,IL-3
R2647 T3779 T3778 punct ",",GM-CSF
R2648 T3780 T3778 cc and,GM-CSF
R2649 T3814 T3808 dobj responses,affecting
R2650 T3781 T3782 compound IFNγ,expression
R2651 T3782 T3771 attr expression,is
R2652 T3783 T3782 prep in,expression
R2653 T3815 T3814 prep in,responses
R2654 T3784 T3785 compound T,lymphocytes
R2655 T3785 T3783 pobj lymphocytes,in
R2656 T3786 T3788 nmod [,]
R2657 T3787 T3788 nummod 30,]
R2658 T3788 T3785 appos ],lymphocytes
R2659 T3789 T3768 punct .,demonstrated
R2660 T3816 T3817 det the,host
R2661 T3790 T3791 amod C-Rel-deficient,mice
R2662 T3791 T3793 nsubj mice,have
R2663 T3792 T3793 advmod also,have
R2664 T3817 T3815 pobj host,in
R2665 T3793 T3793 ROOT have,have
R2666 T3794 T3796 det a,deficiency
R2667 T3795 T3796 amod tissue-specific,deficiency
R2668 T3818 T3817 appos [,host
R2669 T3819 T3820 nummod 31,]
R2670 T3796 T3793 dobj deficiency,have
R2671 T3820 T3817 appos ],host
R2672 T3821 T3793 punct .,have
R2673 T3822 T3828 advmod Therefore,targeted
R2674 T3823 T3828 punct ",",targeted
R2675 T3824 T3828 nsubjpass NF-κB,targeted
R2676 T3853 T3852 cc or,infiltration
R2677 T3854 T3855 punct (,3
R2678 T3825 T3828 aux can,targeted
R2679 T3855 T3857 meta 3,increasing
R2680 T3856 T3855 punct ),3
R2681 T3826 T3828 auxpass be,targeted
R2682 T3857 T3848 conj increasing,stimulating
R2683 T3858 T3859 det the,production
R2684 T3859 T3857 dobj production,increasing
R2685 T3827 T3828 advmod specially,targeted
R2686 T3860 T3859 prep of,production
R2687 T3861 T3862 nsubj tumor,killing
R2688 T3862 T3860 pcomp killing,of
R2689 T3828 T3828 ROOT targeted,targeted
R2690 T3863 T3862 dobj lymphokines,killing
R2691 T3864 T3828 punct .,targeted
R2692 T3865 T3868 nsubj Activation,is
R2693 T3866 T3865 prep of,Activation
R2694 T3829 T3830 aux to,prevent
R2695 T3867 T3866 pobj NF-κB,of
R2696 T3868 T3868 ROOT is,is
R2697 T3830 T3828 xcomp prevent,targeted
R2698 T3869 T3868 acomp important,is
R2699 T3870 T3868 prep in,is
R2700 T3871 T3872 det the,regulation
R2701 T3872 T3870 pobj regulation,in
R2702 T3831 T3832 compound cancer,cell
R2703 T3873 T3872 prep of,regulation
R2704 T3874 T3876 amod CCR-mediated,growth
R2705 T3832 T3833 compound cell,growth
R2706 T3875 T3876 compound tumor,growth
R2707 T3876 T3873 pobj growth,of
R2708 T3877 T3876 cc and,growth
R2709 T3878 T3876 conj metastasis,growth
R2710 T3879 T3868 punct .,is
R2711 T3880 T3882 nsubjpass It,reported
R2712 T3833 T3830 dobj growth,prevent
R2713 T3881 T3882 auxpass was,reported
R2714 T3882 T3882 ROOT reported,reported
R2715 T3883 T3892 mark that,induces
R2716 T3834 T3830 prep by,prevent
R2717 T3884 T3892 nsubj inhibition,induces
R2718 T3885 T3884 prep of,inhibition
R2719 T3886 T3885 pobj NF-κB,of
R2720 T3835 T3836 punct (,1
R2721 T3836 T3834 pobj 1,by
R2722 T3887 T3884 prep by,inhibition
R2723 T3837 T3836 punct ),1
R2724 T3838 T3839 advmod directly,affecting
R2725 T3888 T3887 pobj dehydroxymethyl-epoxyquinomicin,by
R2726 T3889 T3890 punct (,DHMEQ
R2727 T3890 T3888 appos DHMEQ,dehydroxymethyl-epoxyquinomicin
R2728 T3839 T3830 advcl affecting,prevent
R2729 T3891 T3884 punct ),inhibition
R2730 T3892 T3882 ccomp induces,reported
R2731 T3893 T3894 compound cell,death
R2732 T3840 T3843 amod apoptotic,death
R2733 T3894 T3892 dobj death,induces
R2734 T3895 T3894 prep of,death
R2735 T3841 T3842 compound cancer,cell
R2736 T3896 T3897 amod primary,effusion
R2737 T3897 T3898 compound effusion,lymphoma
R2738 T3898 T3895 pobj lymphoma,of
R2739 T3899 T3892 prep by,induces
R2740 T3842 T3843 compound cell,death
R2741 T3900 T3899 pobj inhibition,by
R2742 T3901 T3900 prep of,inhibition
R2743 T3902 T3906 nummod CCR5,]
R2744 T3843 T3839 dobj death,affecting
R2745 T3903 T3904 compound expression,[
R2746 T3844 T3828 punct ",",targeted
R2747 T3845 T3846 punct (,2
R2748 T3846 T3848 meta 2,stimulating
R2749 T3904 T3904 ROOT [,[
R2750 T3905 T3906 nummod 32,]
R2751 T3906 T3901 pobj ],of
R2752 T3847 T3846 punct ),2
R2753 T3907 T3882 punct .,reported
R2754 T3908 T3912 nsubj Activation,increases
R2755 T3909 T3908 prep of,Activation
R2756 T3848 T3828 advcl stimulating,targeted
R2757 T3910 T3909 pobj NF-κB,of
R2758 T3911 T3912 advmod also,increases
R2759 T3912 T3912 ROOT increases,increases
R2760 T3913 T3916 amod CCL5-mediated,motility
R2761 T3914 T3916 amod oral,motility
R2762 T3915 T3916 compound cancer,motility
R2763 T3916 T3912 dobj motility,increases
R2764 T3849 T3850 npadvmod tumor,killing
R2765 T3917 T3916 punct (,motility
R2766 T3918 T3916 appos 5,motility
R2767 T3919 T3916 punct ),motility
R2768 T3850 T3852 amod killing,infiltration
R2769 T3920 T3916 cc and,motility
R2770 T3921 T3922 compound lung,metastasis
R2771 T3922 T3923 compound metastasis,[
R2772 T3851 T3852 compound lymphocytes,infiltration
R2773 T3923 T3912 npadvmod [,increases
R2774 T3924 T3925 nummod 33,]
R2775 T3925 T3923 appos ],[
R2776 T3852 T3848 dobj infiltration,stimulating
R2777 T3926 T3912 punct .,increases
R2778 T3927 T3930 advmod Thus,is
R2780 T3928 T3930 punct ",",is
R2781 T3929 T3930 nsubj it,is
R2782 T3930 T3930 ROOT is,is
R2783 T3931 T3930 acomp possible,is
R2785 T3932 T3938 mark that,involved
R2786 T3933 T3938 nsubjpass inhibition,involved
R2787 T3934 T3933 prep of,inhibition
R2789 T3935 T3934 pobj NF-κB,of
R2790 T3936 T3938 aux could,involved
R2791 T3937 T3938 auxpass be,involved
R2793 T3938 T3930 ccomp involved,is
R2794 T3939 T3938 prep in,involved
R2795 T3940 T3939 pobj CCR5,in
R2797 T3941 T3930 advcl mediated,is
R2798 T3942 T3943 compound tumor,development
R2799 T3943 T3941 dobj development,mediated
R2801 T3944 T3930 punct .,is

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T3024 1499-1509 Negative_regulation denotes inhibition
T3023 1540-1544 Protein denotes CCR5
T3022 1513-1518 Protein denotes NF-κB
T3021 1373-1383 Positive_regulation denotes Activation
T3020 1408-1412 Protein denotes CCL5
T3019 1387-1392 Protein denotes NF-κB
T3018 1337-1347 Negative_regulation denotes inhibition
T3017 1356-1366 Gene_expression denotes expression
T3016 1223-1233 Binding denotes inhibition
T3015 1351-1355 Protein denotes CCR5
T3014 1237-1242 Protein denotes NF-κB
T3013 1106-1116 Positive_regulation denotes Activation
T3012 1120-1125 Protein denotes NF-κB
T3011 871-876 Protein denotes NF-κB
T3010 587-596 Positive_regulation denotes essential
T3009 587-596 Positive_regulation denotes essential
T3008 587-596 Positive_regulation denotes essential
T3007 630-640 Gene_expression denotes expression
T3006 630-640 Gene_expression denotes expression
T3005 630-640 Gene_expression denotes expression
T3004 625-629 Protein denotes IFNγ
T3003 613-619 Protein denotes GM-CSF
T3002 601-611 Protein denotes IL-2, IL-3
T3001 435-440 Protein denotes NF-κB
T3000 194-204 Positive_regulation denotes activation
T2999 208-213 Protein denotes NF-κB
T2998 0-5 Protein denotes NF-κB
R1921 T2999 T3000 themeOf NF-κB,activation
R1922 T3002 T3005 themeOf "IL-2, IL-3",expression
R1924 T3003 T3006 themeOf GM-CSF,expression
R1925 T3004 T3007 themeOf IFNγ,expression
R1926 T3005 T3008 themeOf expression,essential
R1927 T3006 T3009 themeOf expression,essential
R1928 T3007 T3010 themeOf expression,essential
R1931 T3012 T3013 themeOf NF-κB,Activation
R1932 T3014 T3016 themeOf NF-κB,inhibition
R1933 T3015 T3017 themeOf CCR5,expression
R1935 T3016 T3018 causeOf inhibition,inhibition
R1936 T3017 T3018 themeOf expression,inhibition
R1937 T3019 T3021 themeOf NF-κB,Activation
R1938 T3022 T3024 themeOf NF-κB,inhibition